Cocrystal Pharma Announces Nasdaq Closing Bell Ceremony
04 juin 2018 08h00 HE
|
Cocrystal Pharma, Inc.
ATLANTA, GA and BOTHELL, WA, June 04, 2018 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and...
Cocrystal Pharma Provides Update on Reverse Stock Split
23 janv. 2018 16h30 HE
|
Cocrystal Pharma, Inc.
- Reverse stock split to be effective on Wednesday, January 24, 2018 on split-adjusted basis under trading symbol “COCPD” - ATLANTA, GA and BOTHELL, WA, Jan. 23, 2018 (GLOBE NEWSWIRE) --...
Cocrystal Pharma Announces Filing 2017 Third Quarter Financial Statements and Provides Company Update
08 nov. 2017 17h30 HE
|
Cocrystal Pharma, Inc.
ATLANTA, GA and BOTHELL, WA, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (OTCQB: COCP), a company focused on developing novel antiviral therapeutics for human diseases, today announced...